Pamidronate Infusions as Single-agent Therapy for Bone Metastases: A Phase II Trial in Patients with Breast Cancer

By Tyrrell C.T.   Bruning P.F.   May-Levin F.   Rose C.   Mauriac L.   Soukop M.   Ford J.M.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1976-1980

Elsevier

Access to resources Recommend Favorite

Does Supportive Pamidronate Treatment Prevent or Delay the First Manifestation of Bone Metastases in Breast Cancer Patients?

By van Holten-Verzantvoort A.T.M.   Hermans J.   Beex L.V.A.M.   Blijham G.   Cleton F.J.   van Eck-Smit B.C.F.   Sleeboom H.P.   Papapoulos S.E.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Use of Image Processing Techniques to Assess Effect of Disodium Pamidronate in Conjunction with Radiotherapy in Patients with Bone Metastases

By Kouloulias Vassilios E.   Dardoufas Costas E.   Kouvaris John R   Antypas Christos E.   Sandilos Panagiotis H.   Matsopoulos George K.   Vlahos Lambros J.  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 169-174

Informa Healthcare

Access to resources Recommend Favorite

Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells

By        

Molecular Medicine Reports, Vol. 8, Iss. 5, 2013-01 ,pp. : 1499-1504

Spandidos Publications

Access to resources Recommend Favorite

Acute Effects of Pamidronate Administration on Serum Levels of Interleukin-6 in Advanced Solid Tumour Patients with Bone Metastases and their Possible Implications in the Immunotherapy of Cancer with Interleukin-2

By Lissoni P.   Cazzaniga M.   Barni S.   Perego M.S.   Brivio F.   Fumagalli L.   Tancini G.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 304-306

Elsevier

Access to resources Recommend Favorite